Insider · CIK 0001413987

Febbo William J

CIK 0001413987 Name as filed on the most recent filing

Filed as Febbo William J (21)

28 transaction lines · from 21 filings · filed 2007-11-26 to 2024-12-16 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

28 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2024-12-12 P, Open-market purchase OptimizeRx CorpOPRX 100,220, acquired Open Form 4 filing 0001628280-24-051352
2022-08-22 P, Open-market purchase OptimizeRx CorpOPRX 163,642, acquired Open Form 4 filing 0001213900-22-050555
2022-08-19 P, Open-market purchase OptimizeRx CorpOPRX 87,364, acquired Open Form 4 filing 0001213900-22-050555
2022-05-27 P, Open-market purchase Augmedix, Inc.AUGX 59,700, acquired Open Form 4 filing 0001213900-22-030199
2022-02-18 S, Open-market sale OptimizeRx CorpOPRX 3 lines 728,837, disposed Open Form 4 filing 0001213900-22-008987
2022-01-18 S, Open-market sale OptimizeRx CorpOPRX 3 lines 787,772, disposed Open Form 4 filing 0001213900-22-002854
2021-12-15 S, Open-market sale OptimizeRx CorpOPRX 909,130, disposed Open Form 4 filing 0001213900-21-066031
2021-11-15 S, Open-market sale OptimizeRx CorpOPRX 1,369,612, disposed Open Form 4 filing 0001213900-21-060341
2021-10-15 S, Open-market sale OptimizeRx CorpOPRX 1,403,277, disposed Open Form 4 filing 0001213900-21-053524
2021-09-15 S, Open-market sale OptimizeRx CorpOPRX 1,095,623, disposed Open Form 4 filing 0001213900-21-048613
2021-08-16 S, Open-market sale OptimizeRx CorpOPRX 1,007,626, disposed Open Form 4 filing 0001213900-21-043480
2021-03-25 S, Open-market sale OptimizeRx CorpOPRX 3,688,000, disposed Open Form 4 filing 0001213900-21-018006
2021-03-24 S, Open-market sale OptimizeRx CorpOPRX 1,010,000, disposed Open Form 4 filing 0001213900-21-018006
2019-11-06 P, Open-market purchase OptimizeRx CorpOPRX 47,500, acquired Open Form 4 filing 0001213900-19-022200
2018-12-19 P, Open-market purchase OptimizeRx CorpOPRX 19,880, acquired Open Form 4 filing 0001213900-18-017585
2018-11-07 P, Open-market purchase OptimizeRx CorpOPRX 9,792, acquired Open Form 4 filing 0001213900-18-015112
2018-06-22 P, Open-market purchase OptimizeRx CorpOPRX 10,500, acquired Open Form 4 filing 0001213900-18-008163
2016-12-01 P, Open-market purchase OptimizeRx CorpOPRX 3,400, acquired Open Form 4 filing 0001213900-16-019141
2016-11-10 P, Open-market purchase OptimizeRx CorpOPRX 8,100, acquired Open Form 4 filing 0001213900-16-018324
2016-06-09 P, Open-market purchase OptimizeRx CorpOPRX 2 lines 23,324, acquired Open Form 4 filing 0001213900-16-014139
2010-09-29 P, Open-market purchase Merriman Holdings, IncMERR 1,499, acquired Open Form 4 filing 0001179110-10-014503
2010-03-31 P, Open-market purchase Merriman Curhan Ford Group, Inc.MERR 5,001, acquired Open Form 4 filing 0001179110-10-006780
2007-11-26 P, Open-market purchase MCF CorpMEM 14,974, acquired Open Form 4 filing 0001179110-07-022166

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 15
  • Open-market sale 13
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. FEBBO WILLIAM J, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001413987

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.